Organization
Kyowa Kirin China Pharmaceutical
4 clinical trials
1 abstract
Clinical trial
An Open-Label, Multicenter, Single Arm Study to Evaluate the Efficacy and Safety of Anti-CCR4 Monoclonal Antibody Mogamulizumab (KW-0761) in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic TherapyStatus: Recruiting, Estimated PCD: 2025-10-31
Clinical trial
A Multi-center Study Evaluating Efficacy and Safety of Cinacalcet Hydrochloride(HCL) in Calcium, Phosphorus and Intact Parathyroid Hormone(iPTH) Serum Levels in Chinese Chronic Kidney Disease(CKD) Hemodialysis(HD) Patients With Mild, Moderate and Severe Secondary Hyperparathyroidism(SHPT)Status: Completed, Estimated PCD: 2019-04-20
Clinical trial
A Multi-center, Randomized, Placebo-controlled, Double-blinded Then Open 2 Stages Clinical Trial to Evaluate the Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)Status: Completed, Estimated PCD: 2017-02-01
Clinical trial
Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)Status: Completed, Estimated PCD: 2017-08-01
Abstract
Health-related quality of life and economic burden in Chinese patients with cutaneous T-cell lymphoma.Org: Happy Life Tech Co., Ltd, Kyowa Kirin China Pharmaceutical, Department of Dermatology, Peking University First Hospital, Beijing, China, Department of Dermatology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences, Peking Union Medical College, Nanjing, China, Department of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China,